- AI-screener
- Securities US
- Neurogene Inc.

Neurogene Inc.
NGNE
•BATS
•Shares
$19.95
$0.34
1.73%
Updated 5 Sep 20:00
$6.88
$74.49
52 weeks low/high
TTM metrics for the latest quarter under IFRS and their historical dynamics
Valuation
Indicator | TTM Median | |
---|---|---|
P/E | 0.00 23.75 | |
P/B | 0.00 2.20 | |
P/FCF | 0.00 18.30 |
Debts
Indicator | TTM Median | |
---|---|---|
D/E | 0.00 0.43 |
Efficiency
Indicator | TTM Median | |
---|---|---|
ROE | -700.00 25.41 | |
ROA | -350.00 6.00 | |
Net Worth | 0.00 0.20 | |
Quick Ratio | 0.00 1.71 | |
Current Ratio | 0.00 2.83 |
Other ratios
Indicator | TTM Median | |
---|---|---|
Return on tangible equity | -700.00 53.53 |
Revenue
Indicator | TTM Median | |
---|---|---|
EPS | 1.19 0.37 | |
EPS Forecast | 1.23 0.37 | |
Revenue | 0.00 16.00M | |
Gross Profit | 0.00 — | |
EBITDA | 0.00 — |